| Literature DB >> 28932198 |
Dan Sun1,2, Zhaojiang Guo2, Yong Liu1, Youjun Zhang2.
Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR-associated gene Cas9 represent an invaluable system for the precise editing of genes in diverse species. The CRISPR/Cas9 system is an adaptive mechanism that enables bacteria and archaeal species to resist invading viruses and phages or plasmids. Compared with zinc finger nucleases and transcription activator-like effector nucleases, the CRISPR/Cas9 system has the advantage of requiring less time and effort. This efficient technology has been used in many species, including diverse arthropods that are relevant to agriculture, forestry, fisheries, and public health; however, there is no review that systematically summarizes its successful application in the editing of both insect and non-insect arthropod genomes. Thus, this paper seeks to provide a comprehensive and impartial overview of the progress of the CRISPR/Cas9 system in different arthropods, reviewing not only fundamental studies related to gene function exploration and experimental optimization but also applied studies in areas such as insect modification and pest control. In addition, we also describe the latest research advances regarding two novel CRISPR/Cas systems (CRISPR/Cpf1 and CRISPR/C2c2) and discuss their future prospects for becoming crucial technologies in arthropods.Entities:
Keywords: CRISPR/Cas9; insects; non-insect arthropods; prospects; research progress
Year: 2017 PMID: 28932198 PMCID: PMC5592444 DOI: 10.3389/fphys.2017.00608
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1The architecture of the CRISPR/Cas system. (A) Diagram of the CRISPR array. CRISPR array consists of protospacers and repeat sequences. (B) Constituent elements of the crRNA transcribed from the whole CRISPR array and tracrRNA transcribed from repeat sequences of the CRISPR array. (C) Composition of the gRNA. The gRNA consists of crRNA and tracrRNA. (D) Schematic of cleavage by the Cas9 enzyme. The Cas9 enzyme recognizes PAM (NGG) site and cleaves target DNA sequence between the third and fourth bases near the PAM site. (E) Schematic of cleavage by the Cpf1 enzyme, the Cpf1 enzyme recognizes PAM (TTN) site and cleaves target DNA sequence independent of tracrRNA. (F) The repair pathway of double strand break (DSB) mediated by CRISPR system. The DSB induced by the Cas9/sgRNA complex can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). This can result in small insertions or deletions at the target sites (left) and homologous repair with a desired template (right). This can be used to alter the genome by means of gene knockout and knock-in. (G) Schematic of cleavage by the C2c2 CRISPR effector. crRNA directs C2c2 enzyme to cleave single-stranded RNA (ssRNA) target sequences and the cleavage activity is dependent on the protospacer flanking site (PFS).
A comparison of Cas9, Cpf1, and C2c2 in the CRISPR system.
| Target type | dsDNA | dsDNA | ssRNA |
| Single guide RNA | crRNA-tracrRNA | crRNA | crRNA |
| Cleavage recognition | NGG | TTN | PFS |
| Spacer length | 20 bp | >17 bp | 28 bp |
| Cleavage type | Blunt-end cleavage | Staggered-end cleavage | cleaves ssRNA |
| Active cleavage site | RuvC and HNH | RuvC | HEPN |
| Cleavage site inactivation | DNA nickase | cannot cleave | cannot cleave |
The type of Cas9, Cpf1, and C2c2 enzymes cleave target sequence. dsDNA, double strands DNA; ssRNA, single-stranded RNA.
Single guide RNA (sgRNA) directs Cas9, Cpf1, and C2c2 enzyme to cleave target sequence, in this process, Cas9 depends on the complex of crRNA-tracrRNA, while Cpf1 and C2c2 only need crRNA.
The recognition sites of Cas9, Cpf1, and C2c2. Among them, Cas9 recognizes NGG, Cpf1 recognizes TTN (N is any base), C2c2 depends on PFS site.
The length of sgRNA.
The end of target DNA or RNA cleaved by Cas9, Cpf1, and C2c2 enzymes.
The cleavage domains of Cas9, Cpf1, and C2c2 enzymes. Among them, the cleavage domains of Cas9 are RuvC and HNH, the cleavage domains of Cpf1 are two RuvC-like domains, and the cleavage sites of C2c2 are two HEPN-like domains.
If the cleavage site is inactivated, Cas9 formed DNA nickase can still cut dsDNA, however, Cpf1 and C2c2 can't cleave target sequence.
Figure 2The history of the use of CRISPR/Cas9 technology in arthropods. The dotted lines indicate different arthropod classifications. Red circles represent Diptera; black circles represent Hymenoptera; dark blue circles represent Orthoptera; cambridge blue circles represent Coleoptera; gray circle represents Decapoda; green circles represent Lepidoptera; dark red circles represent Cladocera; purple circle represents Acarina; orange circle represents Amphippoda. The citations in this figure are rigorously sorted out according to their accepted dates of the relevant journals. Lepidoptera (Bm, Bombyx mori; Ha, Helicoverpa armigera; Dpl, Danaus plexippus; Dpu, Dendrolimus punctatus; Vc, Vanessa cardui; Jc, Junonia coenia; Ba, Bicyclus anynana; Slitt, Spodoptera littoralis; Slitu, Spodoptera litura; Pm, Papilio machaon; Pxu, Papilio xuthus; Pxy, Plutella xylostella); Coleoptera (Tc, Tribolium castaneum; Gb, Gryllus bimaculatus); Diptera (Dme, Drosophila melanogaster; Ds, Drosophila suzukii; Cq, Culex quinquefasciatus; As, Anopheles stephensi; Ag, Anopheles gambiae; Aa, Aedes aegypti); Orthoptera (Lm, Locusta migratoria); Hymenoptera (Nv, Nasonia vitripennis); Acarina (Tu, Tetranychus urticae); Decapoda (Pc, Palaemon carinicauda); Cladocera (Dma, Daphnia magna); Amphipoda (Ph, Parhyale hawaiensis). For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.
The application of the CRISPR/Cas9 system in insects and non-insect arthropods.
| Diptera | Knockout, Knock-in | mRNA | The CRISPR/Cas9 system was first used to mediate efficient genome engineering in | Gratz et al., | ||
| Knockout | mRNA | Knockout of the | Bassett et al., | |||
| Knockout | mRNA | Targeted multiple genes with different sgRNAs and achieved remarkably effective targeted mutagenesis. | Yu et al., | |||
| Knockout | Transgene | Crossed two transgene vectors that harbored Cas9 and an sgRNA to obtain a Cas9-sgRNA complex. | Kondo and Ueda, | |||
| Knockout, Knock-in | Plasmid, transgene | Performed efficient and complex genomic manipulations using CRISPR/Cas9-mediated HDR. | Gratz et al., | |||
| Knockout, Knock-in | Transgene | Different promoters had different abilities to drive sgRNA expression. | Port et al., | |||
| Knockout | Plasmid, transgene | Induced mutations by injecting an sgRNA into Vasa-Cas9 transgenic fly embryos. | Sebo et al., | |||
| Knockout, Knock-in | Plasmid, transgene | The use of Cas9 nickase and sgRNA pairs can prevent off-target effects when generating indel mutants. | Ren et al., | |||
| Knockout, Knock-in | Plasmid, transgene | Transgenic Cas9 efficiently induced gene knock-in or knockout in | Xue et al., | |||
| Knockout | Plasmid, transgene | A CRISPR/Cas9-mediated conditional mutagenesis system combined with tissue-specific expression of Cas9 was used to temporally and spatially inhibit gene expression. | Xue et al., | |||
| Knock-in | mRNA, transgene | Proposed a two-step method to flexibly modify the fly genome. | Zhang X. et al., | |||
| Knockout, Knock-in | Plasmid, transgene | Donor template and sgRNA plasmids were injected into Cas9 transgenic embryos in | Ren et al., | |||
| Knockout, Knock-in | Plasmid, transgene | Construction of a bicistronic Cas9/sgRNA vector increased the efficiency of gene targeting. | Gokcezade et al., | |||
| Knockout, Knock-in | Plasmid, transgene | Transgenic individuals exhibited more efficient knock-in than non-transgenic individuals. | Port et al., | |||
| Knock-in | Transgene | Converted heterozygous recessive mutations to homozygous loss-of function mutations using mutagenic chain reaction (MCR) technology in | Gantz and Bier, | |||
| Knock-in | Plasmid | The G275E mutation of the nAChR | Zimmer et al., | |||
| LUBEL | Knockout | Plasmid, transgene | Flies with LUBEL mutations exhibited reduced survival and defective climbing in response to heat. | Asaoka et al., | ||
| Knockout | Plasmid | Mutant flies could not produce sufficient energy to promote normal growth. | Quan et al., | |||
| Diptera | Knockout | Plasmid, transgene | An essential transcription factor regulated the expression of a sex-specific gene. | Urban et al., | ||
| Phosphoglycerate kinase | Knockout | Plasmid | CRISPR/Cas9 technology was combined with overlap PCR-based donors to achieve chromosomal gene manipulation in S2 cells. | Böttcher et al., | ||
| Knock-in | mRNA | Tested the efficiency of HDR-mediated genome modifications and resolved a problem associated with “ends-in” recombination. | Yu et al., | |||
| Knockout | Plasmid | CRISPR/Cas9 can be used to analyze or manipulate protein glycosylation pathways. | Mabashi-Asazuma et al., | |||
| Knockout | Plasmid, transgene | Validated a functional gene involved in trans-splicing that affected development in flies. | Gao et al., | |||
| Knockout, Knock-in | Plasmid | Provided a comprehensive toolbox for genome editing in | Kunzelmann et al., | |||
| Knock-in | Plasmid | Proposed a new method of achieving single or multiple allelic substitutions in regions of interest. | Lamb et al., | |||
| Knockout | Plasmid | A tRNA-sgRNA complex can increase the cleavage efficiency of the Cas9 and Cpf1 nucleases. | Port and Bullock, | |||
| Knockout | Plasmid | Verified that the | Chechenova et al., | |||
| Knockout | Plasmid, transgene | Demonstrated that transcription factors can influence | Mendoza-Garcia et al., | |||
| Knockout | Plasmid | Li and Scott, | ||||
| Knockout | mRNA | Demonstrated the analysis of gene functions in a non-model | Tanaka et al., | |||
| Knockout | mRNA, Cas9 protein | Knocking out the miR-309 gene resulted in severe ovarian defects. | Zhang et al., | |||
| Knockout | mRNA | The CRISPR/Cas9 system was used to introduce mutations in | Dong et al., | |||
| Knockout | mRNA | Provided a new vector mosquito management strategy by converting female mosquitoes into harmless male individuals. | Hall et al., | |||
| Knockout, Knock-in | mRNA, Cas9 protein, plasmid | Generated different types of mutations using diverse repair mechanisms. | Kistler et al., | |||
| Knockout, Knock-in | mRNA, Cas9 protein | A transient embryo assay was used to rapidly identify highly effective sgRNAs, promoting gene editing efficiency. | Basu et al., | |||
| Diptera | Knock-in | Plasmid | The CRISPR/Cas9 system was combined with MCR to increase HDR-mediated germ-line gene conversion. | Gantz et al., | ||
| Knockout | mRNA | Demonstrated that the | Itokawa et al., | |||
| Knockout, Knock-in | Plasmid | Targeted female reproduction-related genes to control mosquito populations. | Hammond et al., | |||
| Lepidoptera | Knockout | mRNA | Bi et al., | |||
| Knockout | mRNA | Showed that the | Zhu et al., | |||
| Knockout | mRNA | Investigated the function of the | Koutroumpa et al., | |||
| Knockout | mRNA | Demonstrated that the | Wang J. et al., | |||
| Knockout | mRNA | Essential genes interacted with non-essential genes to produce diverse insect pigmentation patterns. | Khan et al., | |||
| Knockout | Plasmid, mRNA | Provided a novel strategies to destroy pest insect mating. | Chang et al., | |||
| Knockout | mRNA | CRISPR/Cas9 was used to target genes in | Huang et al., | |||
| Knockout | Plasmid | Described the resistance management strategies of major agricultural pests and elucidated the resistance mechanism mode of action using the CRISPR/Cas9 system. | Douris et al., | |||
| Knockout | mRNA | Indicated that the | Liu H. et al., | |||
| Knockout | mRNA | Used the defective phenotypic effects caused by gene mutations to verify the functionality of the CRISPR/Cas9 genome editing system. | Wang et al., | |||
| Knockout | mRNA | Validated the CRISPR/Cas9 technology and assessed mutation efficiency using defective phenotypic effects. | Wei et al., | |||
| Knockout | Plasmid | Verified that the CRISPR/Cas9 system induced multiple gene mutations simultaneously in | Liu Y. et al., | |||
| Knockout | Plasmid | Proved that individuals lacking | Ma et al., | |||
| Knockout | mRNA | Exploited a new method to study the | Zhang et al., | |||
| Lepidoptera | Knockout, Knock-in | Plasmid | Demonstrated that the lack of NHEJ-related factors could increase HR activity using the CRISPR/Cas9 system. | Zhu et al., | ||
| Knockout | Plasmid | Constructed a virus-induced CRISPR/Cas9 system and achieved antiviral responses in | Dong et al., | |||
| Knockout | Plasmid, transgene | Large-segment deletions of the | Chen et al., | |||
| Knockout | Plasmid | U6-driven sgRNAs beginning with four different nucleotides could cause single site mutations in | Zeng et al., | |||
| Knockout | Plasmid | Verified that these six genes are related to sex determination. | Xu et al., | |||
| Knockout | Plasmid | Showed that | Zhang Z. et al., | |||
| Knockout | mRNA | The 20E primary response gene | Li K. et al., | |||
| Knockout | mRNA, Cas9 protein | These two genes are involved in the formation and development of eyespot patterns. | Zhang and Reed, | |||
| Knockout | mRNA | Mutant individuals had four pairs of extra prolegs, which were not observed in wild-type individuals. | Li X. Y. et al., | |||
| Knockout | mRNA | Defined the role of the | Markert et al., | |||
| Knockout | mRNA, Cas9 protein | Verified the three-way stochastic choices that expand color vision in butterflies. | Perry et al., | |||
| Knockout | mRNA | Provided a valuable genomic and genetic technology for studying butterflies and other insects. | Li et al., | |||
| Knockout | mRNA, Cas9 protein | Identified candidate genes by comparative RNA-Seq and verified the function of these candidate genes, which are related to melanin pigmentation, using CRISPR/Cas9. | Zhang L. et al., | |||
| Orthoptera | Knockout | mRNA | Generated loss-of-function mutants for functional genetic studies of locusts and for managing insect pests. | Li Y. et al., | ||
| Coleoptera | Knockout | mRNA | Dopamine and octopamine neurons mediated aversive and appetitive reinforcement, respectively, in crickets. | Awata et al., | ||
| Knockout Knock-in | Plasmid, mRNA | CRISPR/Cas9 technology was used to edit the | Gilles et al., | |||
| Hymenoptera | Knockout | mRNA, Cas9 protein | Established CRISPR/Cas9-directed gene editing in | Li et al., | ||
| Acarina | Knockout | Plasmid, transgene | Demonstrated that an H92R amino acid substitution in the PSST homolog was related to pyridaben resistance and introduced the mutation into the | Bajda et al., | ||
| Decapoda | Knockout | mRNA | A shrimp/decapod genome was successfully edited for the first time. | Gui et al., | ||
| Amphipod | Knockout | mRNA | Described the function of these six Hox genes in crustaceans and indicated the phenotypic effects caused by different Hox gene changes. | Martin et al., | ||
| Cladocera | Knockout | mRNA | CRISPR technology was used to edit the | Nakanishi et al., |